Home/Filings/4/0001209191-14-075560
4//SEC Filing

HERON THERAPEUTICS, INC. /DE/ 4

Accession 0001209191-14-075560

$HRTXCIK 0000818033operating

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:58 PM ET

Size

7.2 KB

Accession

0001209191-14-075560

Insider Transaction Report

Form 4
Period: 2014-12-12
Drazba Brian G.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-12-12+35,00035,000 total
    Exercise: $9.05Exp: 2024-12-12Common Stock (35,000 underlying)
  • Other

    Common Stock

    2014-10-31$7.50/sh+818$6,133818 total
Footnotes (2)
  • [F1]Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2014.
  • [F2]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000818033

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:58 PM ET
Size
7.2 KB